GALECTIN THERAPEUTICS INC. Preferred Stock, Accretion of Redemption Discount
GALECTIN THERAPEUTICS INC. (GALT) reported Preferred Stock, Accretion of Redemption Discount of $173.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-29.
Discontinued › Shareholders' Equity
us-gaap:PreferredStockAccretionOfRedemptionDiscount · last filed 2018-03-29
- GALECTIN THERAPEUTICS INC. preferred stock, accretion of redemption discount for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- GALECTIN THERAPEUTICS INC. preferred stock, accretion of redemption discount for the quarter ending 2016-09-30 was $56.00K, a 1.75% decline year-over-year.
- GALECTIN THERAPEUTICS INC. preferred stock, accretion of redemption discount for the quarter ending 2016-06-30 was $58.00K, a 0.00% change year-over-year.
- GALECTIN THERAPEUTICS INC. preferred stock, accretion of redemption discount for the quarter ending 2016-03-31 was $57.00K, a 0.00% change year-over-year.
- GALECTIN THERAPEUTICS INC. preferred stock, accretion of redemption discount for fiscal 2016 was $173.00K, a 24.45% decline from fiscal 2015.
- GALECTIN THERAPEUTICS INC. preferred stock, accretion of redemption discount for fiscal 2015 was $229.00K, a 0.00% change from fiscal 2014.
- GALECTIN THERAPEUTICS INC. preferred stock, accretion of redemption discount for fiscal 2014 was $229.00K, a 0.00% change from fiscal 2013.
- GALECTIN THERAPEUTICS INC. preferred stock, accretion of redemption discount for fiscal 2013 was $229.00K, a 0.43% decline from fiscal 2012.
| Period end | Preferred Stock, Accretion of Redemption Discount 3 month | Preferred Stock, Accretion of Redemption Discount 6 month | Preferred Stock, Accretion of Redemption Discount 9 month | Preferred Stock, Accretion of Redemption Discount 9 month as first filed | Preferred Stock, Accretion of Redemption Discount 12 month | Preferred Stock, Accretion of Redemption Discount 132 month | Preferred Stock, Accretion of Redemption Discount 135 month | Preferred Stock, Accretion of Redemption Discount 138 month | Preferred Stock, Accretion of Redemption Discount 141 month | Preferred Stock, Accretion of Redemption Discount 144 month | Preferred Stock, Accretion of Redemption Discount 147 month | Preferred Stock, Accretion of Redemption Discount 150 month | Preferred Stock, Accretion of Redemption Discount 153 month | Preferred Stock, Accretion of Redemption Discount 156 month | Preferred Stock, Accretion of Redemption Discount 159 month | Preferred Stock, Accretion of Redemption Discount 162 month | Preferred Stock, Accretion of Redemption Discount 165 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $56.00K derived: sum of 2 quarters · filed 2018-03-29 | $114.00K derived: sum of 3 quarters · filed 2018-03-29 | $173.00K 10-K · filed 2018-03-29 | |||||||||||||
| 2016-09-30 | $56.00K 10-Q · filed 2017-11-07 | $114.00K derived: sum of 2 quarters · filed 2017-11-07 | $173.00K 10-Q · filed 2017-11-07 | $171.00K 10-Q · filed 2016-11-08 | $228.00K derived: sum of 4 quarters · filed 2017-11-07 | ||||||||||||
| 2016-06-30 | $58.00K 10-Q · filed 2017-08-14 | $115.00K 10-Q · filed 2017-08-14 | $172.00K derived: sum of 3 quarters · filed 2017-08-14 | $229.00K derived: sum of 4 quarters · filed 2017-08-14 | |||||||||||||
| 2016-03-31 | $57.00K 10-Q · filed 2017-05-15 | $114.00K derived: sum of 2 quarters · filed 2017-05-15 | $171.00K derived: sum of 3 quarters · filed 2017-05-15 | $229.00K derived: sum of 4 quarters · filed 2017-05-15 | |||||||||||||
| 2015-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28 | $114.00K derived: sum of 2 quarters · filed 2017-03-28 | $172.00K derived: sum of 3 quarters · filed 2017-03-28 | $229.00K 10-K · filed 2017-03-28 | |||||||||||||
| 2015-09-30 | $57.00K 10-Q · filed 2016-11-08 | $115.00K derived: sum of 2 quarters · filed 2016-11-08 | $172.00K 10-Q · filed 2016-11-08 | $229.00K derived: sum of 4 quarters · filed 2016-11-08 | |||||||||||||
| 2015-06-30 | $58.00K 10-Q · filed 2016-08-09 | $115.00K 10-Q · filed 2016-08-09 | $172.00K derived: sum of 3 quarters · filed 2016-08-09 | $229.00K derived: sum of 4 quarters · filed 2016-08-09 | |||||||||||||
| 2015-03-31 | $57.00K 10-Q · filed 2016-05-10 | $114.00K derived: sum of 2 quarters · filed 2016-05-10 | $171.00K derived: sum of 3 quarters · filed 2016-05-10 | $228.00K derived: sum of 4 quarters · filed 2016-05-10 | |||||||||||||
| 2014-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $114.00K derived: sum of 2 quarters · filed 2016-03-15 | $171.00K derived: sum of 3 quarters · filed 2016-03-15 | $229.00K 10-K · filed 2016-03-15 | |||||||||||||
| 2014-09-30 | $57.00K 10-Q · filed 2015-11-09 | $114.00K derived: sum of 2 quarters · filed 2015-11-09 | $172.00K 10-Q · filed 2015-11-09 | $230.00K derived: sum of 4 quarters · filed 2016-03-15 | |||||||||||||
| 2014-06-30 | $57.00K 10-Q · filed 2015-08-10 | $115.00K 10-Q · filed 2015-08-10 | $173.00K derived: sum of 3 quarters · filed 2016-03-15 | $231.00K derived: sum of 4 quarters · filed 2016-03-15 | |||||||||||||
| 2014-03-31 | $58.00K 10-Q · filed 2015-05-11 | $116.00K derived: sum of 2 quarters · filed 2016-03-15 | $174.00K derived: sum of 3 quarters · filed 2016-03-15 | $231.00K derived: sum of 4 quarters · filed 2016-03-15 | $4.33M 10-Q · filed 2014-05-13 | ||||||||||||
| 2013-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $116.00K derived: sum of 2 quarters · filed 2016-03-15 | $173.00K derived: sum of 3 quarters · filed 2016-03-15 | $229.00K 10-K · filed 2016-03-15 | $4.27M 10-K · filed 2014-03-21 | ||||||||||||
| 2013-09-30 | $58.00K 10-Q · filed 2014-11-10 | $115.00K derived: sum of 2 quarters · filed 2014-11-10 | $171.00K 10-Q · filed 2014-11-10 | $229.00K derived: sum of 4 quarters · filed 2015-03-18 | $4.22M 10-Q · filed 2013-11-12 | ||||||||||||
| 2013-06-30 | $57.00K 10-Q · filed 2013-08-14 | $113.00K 10-Q · filed 2014-08-07 | $171.00K derived: sum of 3 quarters · filed 2015-03-18 | $229.00K derived: sum of 4 quarters · filed 2015-03-18 | $4.16M 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $56.00K 10-Q · filed 2014-05-13 | $114.00K derived: sum of 2 quarters · filed 2015-03-18 | $172.00K derived: sum of 3 quarters · filed 2015-03-18 | $229.00K derived: sum of 4 quarters · filed 2015-03-18 | $4.10M 10-Q · filed 2013-05-10 | ||||||||||||
| 2012-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $116.00K derived: sum of 2 quarters · filed 2015-03-18 | $173.00K derived: sum of 3 quarters · filed 2015-03-18 | $230.00K 10-K · filed 2015-03-18 | $4.04M 10-K · filed 2013-03-29 | ||||||||||||
| 2012-09-30 | $58.00K 10-Q · filed 2013-11-12 | $115.00K derived: sum of 2 quarters · filed 2013-11-12 | $172.00K 10-Q · filed 2013-11-12 | $229.00K derived: sum of 4 quarters · filed 2013-11-12 | $3.99M 10-Q · filed 2012-11-09 | ||||||||||||
| 2012-06-30 | $57.00K 10-Q · filed 2013-08-14 | $114.00K 10-Q · filed 2013-08-14 | $171.00K derived: sum of 3 quarters · filed 2013-08-14 | $229.00K derived: sum of 4 quarters · filed 2013-08-14 | $3.93M 10-Q · filed 2012-08-10 | ||||||||||||
| 2012-03-31 | $57.00K 10-Q · filed 2013-05-10 | $114.00K derived: sum of 2 quarters · filed 2013-05-10 | $172.00K derived: sum of 3 quarters · filed 2013-05-10 | $229.00K derived: sum of 4 quarters · filed 2013-05-10 | $3.87M 10-Q · filed 2012-05-11 | ||||||||||||
| 2011-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $115.00K derived: sum of 2 quarters · filed 2013-03-29 | $172.00K derived: sum of 3 quarters · filed 2013-03-29 | $230.00K 10-K · filed 2013-03-29 | $3.81M 10-K · filed 2012-03-30 | ||||||||||||
| 2011-09-30 | $58.00K 10-Q · filed 2012-11-09 | $115.00K derived: sum of 2 quarters · filed 2012-11-09 | $173.00K 10-Q · filed 2012-11-09 | $725.00K derived: sum of 4 quarters · filed 2012-11-09 | $3.76M 10-Q · filed 2011-11-10 | ||||||||||||
| 2011-06-30 | $57.00K 10-Q · filed 2012-08-10 | $115.00K 10-Q · filed 2012-08-10 | $667.00K derived: sum of 3 quarters · filed 2012-08-10 | $1.22M derived: sum of 4 quarters · filed 2012-08-10 | $3.70M 10-Q · filed 2011-08-12 | ||||||||||||
| 2011-03-31 | $58.00K 10-Q · filed 2012-05-11 | $610.00K derived: sum of 2 quarters · filed 2012-05-11 | $1.16M derived: sum of 3 quarters · filed 2012-05-11 | $1.75M derived: sum of 4 quarters · filed 2012-05-11 | |||||||||||||
| 2010-12-31 | $552.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $1.10M derived: sum of 2 quarters · filed 2012-03-30 | $1.70M derived: sum of 3 quarters · filed 2012-03-30 | $2.18M 10-K · filed 2012-03-30 | |||||||||||||
| 2010-09-30 | $551.00K 10-Q · filed 2011-11-10 | $1.15M derived: sum of 2 quarters · filed 2011-11-10 | $1.63M 10-Q · filed 2011-11-10 | ||||||||||||||
| 2010-06-30 | $594.00K 10-Q · filed 2011-08-12 | $1.07M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |